Canada - English - Health Canada

bayer inc - rivaroxaban - tablet - 2.5mg - rivaroxaban 2.5mg - direct factor xa inhibitors

Canada - English - Health Canada

bayer inc - rivaroxaban - tablet - 10mg - rivaroxaban 10mg - direct factor xa inhibitors

Canada - English - Health Canada

bayer inc - rivaroxaban - tablet - 15mg - rivaroxaban 15mg - direct factor xa inhibitors

Canada - English - Health Canada

bayer inc - rivaroxaban - tablet - 20mg - rivaroxaban 20mg - direct factor xa inhibitors

Canada - English - Health Canada

bayer inc - rivaroxaban - tablet - 2.5mg - rivaroxaban 2.5mg - direct factor xa inhibitors

United States - English - NLM (National Library of Medicine)

cardinal health - voriconazole (unii: jfu09i87tr) (voriconazole - unii:jfu09i87tr) - voriconazole 50 mg - vfend is indicated for use in the treatment of the following fungal infections: invasive aspergillosis. in clinical trials, the majority of isolates recovered were aspergillus fumigatus . there was a small number of cases of culture-proven disease due to species of aspergillus other than a. fumigatus (see clinical studies, microbiology). candidemia in nonneutropenic patients and the following candida infections: disseminated infections in skin and infections in abdomen, kidney, bladder wall, and wounds (see clinical studies, microbiology). esophageal candidiasis (see clinical studies, microbiology). serious fungal infections caused by scedosporium apiospermum (asexual form of pseudallescheria boydii ) and fusarium spp. including fusarium solani, in patients intolerant of, or refractory to, other therapy (see clinical studies, microbiology). specimens for fungal culture and other relevant laboratory studies (including histopathology) should be obtained prior to therapy to isolate and identify causative o

United States - English - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg - xyzal is indicated for the relief of symptoms associated with perennial allergic rhinitis in children 6 months to 2 years of age. xyzal is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. the use of xyzal is contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of xyzal, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2)] . patients with end-stage renal disease (clcr <10 ml/min) and patients undergoing hemodialysis children 6 months to 11 years of age with impaired renal function risk summary available data from published literature and postmarketing experience with levocetirizine use in pregnant women are insufficient to identify any drug-associated risks of miscarriage, birth defects, or adverse maternal or fetal outcomes. in animal reproduction studies, there was no evidence of fetal harm with administration

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil 20 mg - adults revatio is indicated for the treatment of pulmonary arterial hypertension (pah) (world health organization [who] group i) in adults to improve exercise ability and delay clinical worsening [see clinical studies (14)] . pediatric patients (1 to 17 years old) revatio is indicated in pediatric patients 1 to 17 years old for the treatment of pulmonary arterial hypertension (pah) (who group i) to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underlie improvements in exercise [see clinical studies (14)] . revatio is contraindicated in patients with: limited published data from randomized controlled trials, case-controlled trials, and case series do not report a clear association with sildenafil and major birth defects, miscarriage, or adverse maternal or fetal outcomes when sildenafil is used during pregnancy. there are risks to the mother and fetus from untreated pulmonary arterial hypertension (see clinical consider

United States - English - NLM (National Library of Medicine)

direct rx - amoxicillin (unii: 804826j2hu) (amoxicillin anhydrous - unii:9em05410q9) - amoxicillin anhydrous 875 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. amoxicillin is indicated in the treatment of infections due to susceptible (only β-lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1.1 infections of the ear, nose, and throat - due to streptococcus species. (α- and β-hemolytic isolates only), streptococcus pneumoniae, staphylococcus spp., or haemophilus influenzae. 1.2 infections of the genitourinary tract - due to escherichia coli, proteus mirabilis, or enterococcus faecalis. 1.3 infections of the skin and skin structure

United States - English - NLM (National Library of Medicine)

mylan institutional inc. - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine 150 mg - ranitidine is indicated in: concomitant antacids should be given as needed for pain relief to patients with active duodenal ulcer; active, benign gastric ulcer; hypersecretory states; gerd; and erosive esophagitis. ranitidine is contraindicated in patients known to have hypersensitivity to the drug or any of the ingredients (see precautions ).